Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel

<i>Background and Objectives</i>: The prognostic nutritional index (PNI), a marker reflecting both nutritional and immune status, has been associated with prognosis in various malignancies. However, evidence in metastatic castration-resistant prostate cancer (mCRPC), particularly from no...

Full description

Saved in:
Bibliographic Details
Main Authors: Hakan Taban, Mustafa Erman, Deniz Can Guven, Burak Yasin Aktas, Feride Yilmaz, Serkan Yaşar, Hasan Cagri Yildirim, Ferit Aslan, Sercan Aksoy
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Medicina
Subjects:
abiraterone
cabazitaxel
enzalutamide
prognostic nutritional index
prostate cancer
Online Access:https://www.mdpi.com/1648-9144/61/6/1105
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/6/1105

Similar Items